Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to assess the efficacy, safety, and side effects among doses
approved by the Food and Drug Administration and higher (not FDA approved) doses of
olanzapine in patients with schizophrenia or schizoaffective disorder.